Small-cell lung cancer in never-smokers: A case series (English)
- New search for: Tavares e Castro, Ana
- New search for: Clemente, Joana
- New search for: Carvalho, L.
- New search for: Freitas, Sara
- New search for: Cemlyn-Jones, Jessica
- New search for: Tavares e Castro, Ana
- New search for: Clemente, Joana
- New search for: Carvalho, L.
- New search for: Freitas, Sara
- New search for: Cemlyn-Jones, Jessica
In:
Lung cancer
;
93
;
82-87
;
2016
-
ISSN:
- Article (Journal) / Print
-
Title:Small-cell lung cancer in never-smokers: A case series
-
Contributors:Tavares e Castro, Ana ( author ) / Clemente, Joana ( author ) / Carvalho, L. ( author ) / Freitas, Sara ( author ) / Cemlyn-Jones, Jessica ( author )
-
Published in:Lung cancer ; 93 ; 82-87
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2016-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.99424
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.99424 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 93
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)Lim, Sun Min / Cho, Byoung Chul / Kim, Sang-We / Kang, Seok Yun / Heo, Dae Seog / Kim, Heung Tae / Lee, Dae Ho / Kim, Dong-Wan / Jung, Minkyu / Choi, Jin-Hyuk et al. | 2016
- 9
-
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitorsMeniawy, Tarek M. / Lake, Richard A. / McDonnell, Alison M. / Millward, Michael J. / Nowak, Anna K. et al. | 2016
- 17
-
Crizotinib-induced fatal fulminant liver failurevan Geel, Robin M.J.M. / Hendrikx, Jeroen J.M.A. / Vahl, Jelmer E. / van Leerdam, Monique E. / van den Broek, Daan / Huitema, Alwin D.R. / Beijnen, Jos H. / Schellens, Jan H.M. / Burgers, Sjaak A. et al. | 2016
- 20
-
Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinibvan den Boogaart, Vivian E.M. / de Lussanet, Quido G. / Houben, Ruud M.A. / de Ruysscher, Dirk / Groen, Harry J.M. / Marcus, J.Tim / Smit, Egbert F. / Dingemans, Anne-Marie C. / Backes, Walter H. et al. | 2016
- 28
-
Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancerTönnies, Simone / Tönnies, Mario / Kollmeier, Jens / Bauer, Torsten T. / Förster, Gregor J. / Kaiser, Dirk / Wernecke, Klaus-Dieter / Pfannschmidt, Joachim et al. | 2016
- 35
-
Cigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMTLi, Dandan / Zhang, Lu / Zhou, Junhao / Chen, Hong et al. | 2016
- 43
-
Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancerHoriike, Atsushi / Takeuchi, Kengo / Uenami, Takeshi / Kawano, Yuko / Tanimoto, Azusa / Kaburaki, Kyohei / Tambo, Yuichi / Kudo, Keita / Yanagitani, Noriko / Ohyanagi, Fumiyoshi et al. | 2016
- 47
-
The impact of clinical parameters on progression-free survival of non-small cell lung cancer patients harboring EGFR-mutations receiving first-line EGFR-tyrosine kinase inhibitorsChen, Yu-Mu / Lai, Chien-Hao / Chang, Huang-Chih / Chao, Tung-Ying / Tseng, Chia-Cheng / Fang, Wen-Feng / Wang, Chin-Chou / Chung, Yu-Hsiu / Wang, Yi-Hsi / Su, Mao-Chang et al. | 2016
- 55
-
K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literatureMengoli, Maria Cecilia / Barbieri, Fausto / Bertolini, Federica / Tiseo, Marcello / Rossi, Giulio et al. | 2016
- 59
-
Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancerTan, Chee-Seng / Cho, Byoung-Chul / Soo, Ross A. et al. | 2016
- 69
-
Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancerHirose, Takashi / Fujita, Ken-ichi / Kusumoto, Sojiro / Oki, Yasunari / Murata, Yasunori / Sugiyama, Tomohide / Ishida, Hiroo / Shirai, Takao / Nakashima, Masanao / Yamaoka, Toshimitsu et al. | 2016
- 77
-
Medical treatment involving investigational drugs and genetic profile of thymic carcinomaAsao, Tetsuhiko / Fujiwara, Yutaka / Sunami, Kuniko / Kitahara, Shinsuke / Goto, Yasushi / Kanda, Shintaro / Horinouchi, Hidehito / Nokihara, Hiroshi / Yamamoto, Noboru / Ichikawa, Hitoshi et al. | 2016
- 82
-
Small-cell lung cancer in never-smokers: A case seriesTavares e Castro, Ana / Clemente, Joana / Carvalho, L. / Freitas, Sara / Cemlyn-Jones, Jessica et al. | 2016
- 88
-
Induction therapy followed by surgical resection in Stage-III thimic epithelial tumors: Long-term results from a multicentre analysis of 108 casesCardillo, Giuseppe / Lucchi, Marco / Marulli, Giuseppe / Infante, Maurizio / Leuzzi, Giovanni / Mussi, Alfredo / Carleo, Francesco / Facciolo, Francesco / Voulaz, Emanuele / Rapicetta, Cristian et al. | 2016
- 95
-
Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapyPérol, Maurice / Ciuleanu, Tudor-Eliade / Arrieta, Oscar / Prabhash, Kumar / Syrigos, Konstantinos N. / Goksel, Tuncay / Park, Keunchil / Kowalyszyn, Ruben Dario / Pikiel, Joanna / Lewanski, Conrad R. et al. | 2016
- 104
-
Acknowledgement to Reviewers 2015| 2016
- v
-
Contents| 2016
-
Editorial Board| 2016